Piero Anversa, Italian scientist and director of regenerative medicine at the Brigham and Women’s Hospital of Harvard University in Boston is ready to perform the first biological by-pass in history. This evening in Milan during a meeting called ‘Futuro della Sanita’ (The Future of Health), Anversa explained that he has identified human coronary stem cells able to develop into coronary artery tissue.
He said, “My dream is for someone to have a heart attack, come to the hospital, and return home healthy.” For that to occur, it will be necessary to reproduce muscle and the large coronary vessels.
No Waiting for the Stem Cell Research Debate To Finish
While the debate on stem cell research rages on, Donald Cecil couldn’t afford to wait for research. Donald badly needed treatment for his heart which was damaged by a series of heart attacks. Luckily, he found a stem cell treatment, Vescell in Thailand by using […]
Fat around the waist is commonly seen as a contributing factor to heart attack. Ironically, a company is now testing whether adult stem cells from fat could help prevent long-term damage after a heart attack.
A new medical team is now investigating whether adult stem cells harvested from a person’s own fat, delivered shortly after a heart attack, could prevent some of the cardiac muscle damage that results from blocked arteries.
During a heart attack, blood vessels that deliver blood to the heart muscle are blocked. The lack of oxygen slowly kills the tissue. San Diego-based Cytori Therapeutics has developed
Harvard Stem Cell Institute (HSCI) scientists collaborating with researchers at the University of Pennsylvania have developed a “genome-editing” approach for permanently reducing cholesterol levels in mice through a single injection, a development that could reduce the risk of heart attacks in humans by 40 to 90 percent.
“For the first iteration of an experiment, this was pretty remarkable,” said Kiran Musunuru of HSCI, an assistant professor in Harvard’s Department of Stem Cell and Regenerative Biology (SCRB), and a cardiologist at Harvard-affiliated Brigham and Women’s Hospital. Musunuru stressed, however, that it could take a decade of concerted effort to get this
Concha Herrera Arroyo, from El Pais
The Cardiology department and the Area of Cell Therapy of Cordoba hospital Reina Sofia are carrying out clinical tests with patients who have suffered from a severe heart attack. With the implantation of the patient’s stem cells, the heart regenerates thus improving its wall motion, that is, its cardiac performance.
Indeed for the last four years, the Area of Cell Therapy of Cordoba hospital, led by haematologist Dr. Concha Herrera, has been implementing a therapy program with adult stem cells in patients with heart-related problems. However, this therapy is not a service the hospital